New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Structure Therapeutics Inc.
GPCR
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

2B

Biotechnology

Next Earning date - 12 Nov 2024

2B

Biotechnology

Next Earning date - 12 Nov 2024

37.81USD
Shape-1.60 ( -4.06%)
Market Open
favorite-chart

Relative Strenght

28
favorite-chart

Volume Buzz

-56%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

50%

Quote Panel

Shape
Updated October 23, 2024
1W -0.53 % 1M -10.47 % 3M 8.72 % 1Y -42.68 %

Key Metrics

Shape
  • Market Cap

    2.16B


  • Shares Outstanding

    57.20M


  • Share in Float

    54.78M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    37.81


  • Average Volume

    669315


  • Beta

    -5.132897


  • Range

    26.61-75.017


  • Industry

    Biotechnology


  • Website

    https://structuretx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1695.72x

P/S Ratio

2.12x

P/B Ratio

0.0

Debt/Equity

-7562.1%

Net Margin

$-2.2

EPS

How GPCR compares to sector?

P/E Ratio

Relative Strength

Shape

GPCR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$56M

ShapeNaN%

2025-Revenue

$0.76

Shape-43%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Morgan Stanley

initialise

Previous: Not converted

2024-09-23

Now: Overweight

Cantor Fitzgerald

initialise

Previous: Not converted

2024-04-09

Now: Overweight

Guggenheim

initialise

Previous: Not converted

2023-02-28

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-1.14
vs -0.00

Q1.23

arrow
arrow

N/A

-0.25
vs -0.51

Q2.23

arrow
arrow

N/A

-0.60
vs -0.55

Q3.23

arrow
arrow

N/A

-0.62
vs -0.55

Q4.23

arrow
arrow

N/A

-0.17
vs -1.14

Q1.24

arrow
arrow

N/A

-0.19
vs -0.25

Q2.24

arrow
arrow

N/A

-0.18
vs -0.60

Q3.24

arrow
arrow

N/A

-0.19
vs -0.62

Q4.24

arrow
arrow

N/A

-0.21
vs -0.17

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

1.3M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+13%

0.13
vs NA

Q4.22

arrow
arrow

+10%

0.1
vs 0.13

Q1.23

arrow
arrow

-8%

-0.08
vs 0.1

Q2.23

arrow
arrow

-11%

-0.11
vs -0.08

Q3.23

arrow
arrow

-12%

-0.12
vs -0.11

Q4.23

arrow
arrow

-5%

-0.05
vs -0.12

Q1.24

arrow
arrow

-6%

-0.06
vs -0.05

Q2.24

arrow
arrow

-3%

-0.03
vs -0.06

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News